Swiss National Bank raised its position in ICU Medical, Incorporated (NASDAQ:ICUI) by 4.2% during the fourth quarter, HoldingsChannel reports. The firm owned 27,219 shares of the medical instruments supplier’s stock after purchasing an additional 1,100 shares during the period. Swiss National Bank’s holdings in ICU Medical were worth $5,879,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently modified their holdings of the company. Exane Derivatives acquired a new stake in shares of ICU Medical in the 4th quarter worth $100,000. Eagle Boston Investment Management Inc. acquired a new stake in shares of ICU Medical in the 3rd quarter worth $200,000. Raymond James Trust N.A. acquired a new stake in shares of ICU Medical in the 4th quarter worth $204,000. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of ICU Medical by 39.2% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 984 shares of the medical instruments supplier’s stock worth $213,000 after acquiring an additional 277 shares during the last quarter. Finally, Ameritas Investment Partners Inc. increased its stake in shares of ICU Medical by 4.0% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 1,321 shares of the medical instruments supplier’s stock worth $228,000 after acquiring an additional 51 shares during the last quarter. 75.52% of the stock is owned by institutional investors and hedge funds.
Separately, Zacks Investment Research downgraded ICU Medical from a “buy” rating to a “hold” rating in a research report on Wednesday, January 10th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $266.00.
In other ICU Medical news, CFO Scott E. Lamb sold 23,624 shares of ICU Medical stock in a transaction dated Thursday, January 4th. The stock was sold at an average price of $220.00, for a total value of $5,197,280.00. Following the completion of the transaction, the chief financial officer now directly owns 29,723 shares of the company’s stock, valued at approximately $6,539,060. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Robert S. Swinney sold 724 shares of ICU Medical stock in a transaction dated Friday, January 19th. The shares were sold at an average price of $235.00, for a total value of $170,140.00. Following the completion of the transaction, the director now directly owns 14,830 shares of the company’s stock, valued at $3,485,050. The disclosure for this sale can be found here. Insiders own 13.60% of the company’s stock.
ICU Medical Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.